The new findings should help public health officials more quickly and accurately determine which strains to include in the annual flu vaccine.
The study, supported in part by the National Institutes of Health (NIH), appears online in advance of print in the journal Nature.
The researchers analyzed full gene sequences of seasonal influenza virus samples collected from the world’s temperate regions north and south of the equator. Their data comprised full genetic sequences of 1,302 isolates of influenza A virus collected over 12 years from New Zealand and New York state.
By quantifying the degree of genetic diversity among the strains’ subtypes, gene segments and geographic locations, the researchers were able to detect patterns indicating that virus strains do not persist from one flu season to the next in the temperate regions. Therefore, the researchers deduced, new flu strains emerge annually from the tropics.
The international team of researchers included Jeffery K. Taubenberger, M.D., Ph.D., of the National Institute of Allergy and Infectious Diseases, NIH; Cecile Viboud, Ph.D., of NIH’s Fogarty International Center; and Edward C. Holmes, Ph.D., of Pennsylvania State University, who received funding from the National Institute of General Medical Sciences, NIH. The gene sequence information is stored in an NIAID-supported and publicly accessible database, the Influenza Genome Sequencing Project http://www3.niaid.nih.gov/research/resources/mscs/Influenza/.
ARTICLE: A Rambaut et al. The genomic and epidemiological dynamics of human influenza A virus. Nature DOI: 10.1038/nature06945 (2008).
WHO: NIAID Director Anthony S. Fauci, M.D., is available to comment. Jeffery K. Taubenberger, M.D., Ph.D., Laboratory of Infectious Diseases, NIAID, is also available.
CONTACT: To schedule interviews, contact Anne A. Oplinger in the NIAID Office of Communications and Government Relations at 301-402-1663 or firstname.lastname@example.org.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.
The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases.
News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy